Crossref
Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment
SECI Oncology · 2014
DOI: 10.18056/seci2014.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift SECI Oncology, 2014. Verfasst von Ashraf Zedan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zedan, A. (2014). Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment. SECI Oncology. https://doi.org/10.18056/seci2014.6
Vancouver
Zedan A. Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment. SECI Oncology. 2014. doi:10.18056/seci2014.6
BibTeX
@article{Zedan2014,
author = {Zedan, Ashraf},
title = {Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment},
journal = {SECI Oncology},
year = {2014},
doi = {10.18056/seci2014.6}
}
EUVIMED